Funds Phase 1b clinical trials in immuno-oncology and ulcerative colitis and expansion of microbiome-based product pipeline to other indications Series B funding round co-led by new investors Tencent and Flerie Invest, with additional participation from British Patient Capital and existing investors Cambridge Innovation Capital, IP Group and Seventure Company on the trajectory to become … Continue reading Microbiotica raises £50 million ($67 million) to advance pipeline of microbiome-based therapeutics